Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam toluenesulfonate versus propofol for painless gastroenteroscopy
ChiCTR2000037917Phase 4Recruiting
- Sponsor
- Jingmen Second People's Hospital
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol (3 arms), sponsored by Jingmen Second People's Hospital. Primary endpoints: Ramsay Sedation score, Heart rate and 8 more. Started May 2020; status: recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2000037917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037917.